Kyle Hess

PGY-2 Emergency Medicine Pharmacy Resident @MayoPharmRes

[Justin Moore @moore_wjustin]

Great debate of what to do with mecA/PBP2A negative, oxacillin-resistant Staph aureus Cx results

A: Expert panel rec’s report & treat as MRSA, given highly elevated oxa MIC as opposed to BORSA that traditionally has MIC of 2 or less. Likely explained by blaZ #IDWeek2023

[Stefano Giulieri @stefanoinoz]

Think you know already know everything about beta-lactam resistance in Staphylococcus aureus? Think twice! In my commentary in #AACJournal I describe the hidden side of oxacillin resistance @ASMicrobiology https://t.co/LxJtD0gaBt

[Mayo Clinic Pharmacy Residency Programs @MayoPharmRes]

Kyle A. Hess, PharmD, BCPS - "All-In on Insulin? Use of High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker Overdose". Pharmacology CE available for pharmacists, physicians, physician assistants, and nurse practitioners. #TwitteRx @MayoMedEd
https://t.co/npRnH5YJiW

[Mayo Clinic Infectious Diseases @MayoClinicINFD]

Publication Alert

Description of a case of S. aureus bloodstream infection and infective endocarditis with discordance between mecA/mecC genotypic results and phenotypic susceptibility testing. @omarabusaleh15 @Stevens_AK

https://t.co/kV61fxVpa1

[Jonathan Ryder, MD @JonathanRyderMD]

#IDTwitter will like this case, invoking conversations of BORSA/MODSA and the like.

What to do when genotypic and phenotypic testing don't align in Staph aureus?

[Cesar Arias @SuperBugDoc]

Hot-off-the-press #AACJournal. Challenging Clinical Case on a patient with S. aureus endocarditis and discrepant mecA/mecC PCR. A rea therapeutic conundrum! @ASMicrobiology @asm_tmc
https://t.co/aavFhVl98U

[Ryan Stevens @Stevens_AK]

One day @MayoClinicINFD Twitterless Dan DeSimone and I had a pt w/ persistent MSSA bacteremia on cefazolin and had an ox MIC of 2… we said “right right… the cefazolin shouldn’t be inferior to an ASP… we know the data… but what about the high ox MIC?”

https://t.co/MbES347rcz

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕️⚡️⚡️#JCM @JClinMicro
Retrospective Evaluation of the Association of Oxacillin MIC on Acute Treatment Outcomes with Cefazolin and Antistaphylococcal Penicillins in MSSA Bacteremia #IDTwitter
https://t.co/bz3VEu5YWP

[Kyle Hess @KyleHessPharmD]

My PGY-1 research project just got published! Thankful for my amazing research mentors ⁦@Stevens_AK⁩ and ⁦@kjkpharm⁩ as well as all of ⁦@MayoClinicINFD⁩! https://t.co/KjJPXlcN2F

[Mayo Clinic Pharmacy Residency Programs @MayoPharmRes]

Kyle A. Hess, PharmD @KyleHessPharmD - "Early Multimodal Vasopressors in Septic Shock: When is it Time for Full-Court Press(ors)?". Pharmacology CE available for pharmacists, physicians, physician assistants, and nurse practitioners. #TwitteRx @MayoMedEd
https://t.co/WGQQ2ZjHKo

[Kyle Hess @KyleHessPharmD]

@iamcrsmith @accpemedprn Here are a couple of additional studies you could take a look at if you are interested in the topic! Who knows how practice might change in the future: https://t.co/XDilkG0EHd, https://t.co/YgUwKDibrT

[Kyle Hess @KyleHessPharmD]

@iamcrsmith @accpemedprn I agree though, I have many doubts due to limitations of this trial (n = 40 in DOAC group, 0.6 mg/kg alteplase not used in US, no power calculation, retrospective design). I am definitely not ready to recommend lytics in my DOAC patients with AIS

[ACCP EMED PRN @accpemedprn]

Dr. Kyle Hess, EM PGY2 resident at Mayo Clinic will present on "Intravenous Thrombolysis with Alteplase at 0.6 mg/kg in Patients with Ischemic Stroke Taking DOAC" published this year in J Am Heart Assoc.

[Cassie Schmitt, PharmD @cassinetobacter]

🚨🚨 Calling all EM PGY2 Candidates 💊🚑
Are you looking for a pharmacy PGY2 in EM?
Consider our program at @MayoPharmRes!
👇👇Here's a thread why 👇👇

[Kyle Hess @KyleHessPharmD]

@GilbertPharmD Mayo Clinic will be recruiting for a Peds PGY2 this year with the amazing RPD @laurmargzpharmd! I’m an EM PGY2 but am happy to answer any questions about Mayo in general and have experience with many of our incredible Peds Preceptors!

[Alicia Mattson @AM_EM_PharmD]

We are recruiting this year for the PGY2 EM program @MayoPharmRes! Come join us at a virtual open house on 11/7! @CBthePHARMD @cassinetobacter @KyleHessPharmD @KellynEPharmD @accpemedprn

[Cassie Schmitt, PharmD @cassinetobacter]

Starting out pharmacy week with many congratulations to pharmacy mentors, preceptors, colleagues, and friends selected for @ACCP awards this year! @Thedaringdonna @CBthePHARMD @Dre_pharmd @nei_scott and @jenna_k_lovely

[Andy Jatis, PharmD, BCPS, BCCCP @jatis_rx]

Crit Care Lit Review 📒 Vasopressin 💉

VASST: Adding vaso ⬇️catecholamine dose and may reduce mortality for those with lower NE dose (<15 mcg/min) in septic shock
VANISH: Adding vaso early to NE may ⬇️ need for RRT
VANCS: Vaso ⬇️acute renal failure in vasoplegic shock #PharmICU

[Kyle Hess @KyleHessPharmD]

I got to celebrate finishing my Grand Rounds on early multimodal vasopressors with a Squeeze Squad pin from @CuriousBoxwood! Thank you @pwierusz, @cassinetobacter, @AM_EM_PharmD, and Francis Manuel for all of your help in preparing for my presentation!